Literature DB >> 6215979

Chemotherapy of large bowel cancer.

H L Davis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215979

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  16 in total

1.  [Regional chemotherapy of liver metastases].

Authors:  A Encke; C Hottenrott; M Lorenz
Journal:  Langenbecks Arch Chir       Date:  1987

Review 2.  How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.

Authors:  P Ragnhammar; H Blomgren
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

3.  Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants.

Authors:  T D Schmittgen; A Koolemans-Beynen; T E Webb; T J Rosol; J L Au
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

Authors:  W Scheithauer; H Rosen; G V Kornek; C Sebesta; D Depisch
Journal:  BMJ       Date:  1993-03-20

5.  Primary and metastatic liver lesions of clinical colorectal cancer differ in chemosensitivity.

Authors:  Y Maehara; Y Sakaguchi; Y Emi; T Kusumoto; S Kohnoe; M Mori; K Sugimachi
Journal:  Int J Colorectal Dis       Date:  1990-05       Impact factor: 2.571

6.  Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose.

Authors:  G W Visser; G C Gorree; G J Peters; J D Herscheid
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection.

Authors:  J G Fortner; J S Silva; R B Golbey; E B Cox; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

8.  Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy.

Authors:  J G Fortner; J S Silva; E B Cox; R B Golbey; H Gallowitz; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

9.  Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients.

Authors:  Shinichi Sugimoto; Kuniyuki Katano; Akiyoshi Kanazawa; Hiroshi Yoshimura; Akihiko Kidani; Hiroshi Takeda; Masato Makino; Nobuhiro Ozaki; Tsuneo Tanaka; Masahide Ikeguchi
Journal:  J Exp Clin Cancer Res       Date:  2009-08-07

10.  Relationship between systemic 5-FU passage and response in colorectal cancer patients treated with intrahepatic chemotherapy.

Authors:  G Milano; M Namer; J L Boublil; R Khater; M Frenay; A Thyss; J Bourry; C Philip; N Renée; J N Bruneton
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.